Scientists look at autophagy as possible target for Alzheimer's treatment

10/7/2013 | Genetic Engineering & Biotechnology News

Neurons that do not undergo autophagy tend to accumulate beta amyloid inside instead of around them, resulting in neuronal death and subsequent memory loss, according to scientists from the Riken Brain Science Institute in Japan. The process of autophagy is believed to be disrupted in Alzheimer's disease patients. "To control amyloid beta metabolism including its secretion is a key to controlling the disease. Autophagy might therefore be a potential drug target for the treatment of Alzheimer's disease," lead researcher Per Nilsson said.

View Full Article in:

Genetic Engineering & Biotechnology News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC